| Year |
Citation |
Score |
| 2023 |
Tan X, Xiao GY, Wang S, Shi L, Zhao Y, Liu X, Yu J, Russell WK, Creighton CJ, Kurie JM. EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. The Journal of Clinical Investigation. PMID 36757799 DOI: 10.1172/JCI165863 |
0.411 |
|
| 2022 |
Chen Z, Zheng L, Chen Y, Liu X, Kawakami M, Mustachio LM, Roszik J, Ferry-Galow KV, Parchment RE, Liu X, Andresson T, Duncan G, Kurie JM, Rodriguez-Canales J, Liu X, et al. Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis. Cancer Biology & Therapy. 23: 265-280. PMID 35387560 DOI: 10.1080/15384047.2022.2054242 |
0.396 |
|
| 2022 |
Kim EJ, Kim JS, Lee S, Cheon I, Kim SR, Ko YH, Kang K, Tan X, Kurie JM, Ahn YH. ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells. Cancer Letters. 533: 215601. PMID 35176421 DOI: 10.1016/j.canlet.2022.215601 |
0.353 |
|
| 2022 |
Wilson AN, Chen B, Liu X, Kurie JM, Kim J. A Method for Orthotopic Transplantation of Lung Cancer in Mice. Methods in Molecular Biology (Clifton, N.J.). 2374: 231-242. PMID 34562257 DOI: 10.1007/978-1-0716-1701-4_20 |
0.371 |
|
| 2021 |
Tan X, Banerjee P, Liu X, Yu J, Lee S, Ahn YH, Creighton CJ, Kurie JM. Transcriptional control of a collagen deposition and adhesion process that promotes lung adenocarcinoma growth and metastasis. Jci Insight. PMID 34874914 DOI: 10.1172/jci.insight.153948 |
0.337 |
|
| 2021 |
Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, ... ... Kurie J, et al. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nature Communications. 12: 7081. PMID 34873156 DOI: 10.1038/s41467-021-27341-1 |
0.372 |
|
| 2021 |
Bota-Rabassedas N, Banerjee P, Niu Y, Cao W, Luo J, Xi Y, Tan X, Sheng K, Ahn YH, Lee S, Parra ER, Rodriguez-Canales J, Albritton J, Weiger M, Liu X, ... ... Kurie JM, et al. Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity. Cell Reports. 35: 109009. PMID 33882319 DOI: 10.1016/j.celrep.2021.109009 |
0.372 |
|
| 2020 |
Liu X, Lu Y, Chen Z, Liu X, Hu W, Zheng L, Chen Y, Kurie JM, Shi M, Mustachio LM, Andresson T, Fox S, Roszik J, Kawakami M, Freemantle S, et al. The Ubiquitin Specific Protease USP18 Promotes Lipolysis, Fatty Acid Oxidation and Lung Cancer Growth. Molecular Cancer Research : McR. PMID 33380466 DOI: 10.1158/1541-7786.MCR-20-0579 |
0.304 |
|
| 2020 |
Kawakami M, Mustachio LM, Chen Y, Chen Z, Liu X, Wei CH, Roszik J, Kittai AS, Danilov AV, Zhang X, Fang B, Wang J, Heymach JV, Tyutyunyk-Massey L, Freemantle SJ, ... Kurie JM, et al. A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis and Metastasis in Aneuploid Cancers. Molecular Cancer Therapeutics. PMID 33277443 DOI: 10.1158/1535-7163.MCT-19-0987 |
0.404 |
|
| 2020 |
Tan X, Shi L, Banerjee P, Liu X, Guo HF, Yu J, Bota-Rabassedas N, Rodriguez BL, Gibbons DL, Russell WK, Creighton CJ, Kurie JM. A pro-tumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. The Journal of Clinical Investigation. PMID 32931483 DOI: 10.1172/Jci137186 |
0.42 |
|
| 2020 |
Peng DH, Rodriguez BL, Diao L, Chen L, Wang J, Byers LA, Wei Y, Chapman HA, Yamauchi M, Behrens C, Raso G, Soto LMS, Cuentes ERP, Wistuba II, Kurie JM, et al. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 T cell exhaustion. Nature Communications. 11: 4520. PMID 32908154 DOI: 10.1038/S41467-020-18298-8 |
0.352 |
|
| 2020 |
Dmitrovsky E, Kawakami M, Liu XI, Freemantle SJ, Kurie JM. TRIGGERING ANAPHASE CATASTROPHE TO COMBAT ANEUPLOID CANCERS. Transactions of the American Clinical and Climatological Association. 131: 82-94. PMID 32675848 |
0.362 |
|
| 2020 |
Yamauchi M, Gibbons DL, Zong C, Fradette JJ, Bota-Rabassedas N, Kurie JM. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 32442601 DOI: 10.1016/J.Matbio.2020.05.001 |
0.317 |
|
| 2020 |
Hong L, Negrao MV, Dibaj SS, Chen R, Reuben A, Bohac JM, Liu X, Skoulidis F, Gay CM, Cascone T, Mitchell KG, Tran HT, Le X, Byers LA, Sepesi B, ... ... Kurie JM, et al. Programmed Death Ligand 1 Heterogeneity and its Impact on Benefit from Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32389639 DOI: 10.1016/J.Jtho.2020.04.026 |
0.351 |
|
| 2020 |
Tan X, Banerjee P, Rutaganira FUN, Basu K, Bota-Rabassedas N, Guo HF, Grzeskowiak CL, Liu X, Yu J, Shi L, Peng DH, Rodriguez BL, Zhang J, Zheng V, Duose DY, ... ... Kurie JM, et al. Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002) Science Translational Medicine. 12. PMID 32188723 DOI: 10.1126/Scitranslmed.Abb5995 |
0.318 |
|
| 2020 |
Tan X, Banerjee P, Pham EA, Rutaganira FUN, Basu K, Bota-Rabassedas N, Guo HF, Grzeskowiak CL, Liu X, Yu J, Shi L, Peng DH, Rodriguez BL, Zhang J, Zheng V, ... ... Kurie JM, et al. PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Science Translational Medicine. 12. PMID 31969487 DOI: 10.1126/Scitranslmed.Aax3772 |
0.443 |
|
| 2019 |
Lin SH, Lin Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Simon G, Skoulidis F, Chang JY, et al. Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31778797 DOI: 10.1016/J.Jtho.2019.10.024 |
0.457 |
|
| 2019 |
Yu X, Zhang Y, Wu B, Kurie JM, Pertsemlidis A. The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5. Molecular Therapy Oncolytics. 14: 288-298. PMID 31508486 DOI: 10.1016/J.Omto.2019.07.004 |
0.359 |
|
| 2019 |
Zheng L, Chen Z, Kawakami M, Chen Y, Roszik J, Mustachio LM, Kurie JM, Villalobos P, Lu W, Behren C, Mino B, Solis LM, Silvester J, Thu KL, Cescon DW, et al. Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. Molecular Cancer Therapeutics. PMID 31358662 DOI: 10.1158/1535-7163.Mct-18-0864 |
0.534 |
|
| 2019 |
Elamin Y, Robichaux J, Carter B, Altan M, Gibbons D, Fossella F, Simon G, Lam V, Blumenschein G, Tsao A, Kurie J, Mott F, Negrao M, Hu L, He J, et al. MA09.03 Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology. 14: S282-S283. DOI: 10.1016/J.Jtho.2019.08.567 |
0.478 |
|
| 2019 |
Sepesi B, Cascone T, William W, Lin H, Leung C, Weissferdt A, Walsh G, Rice D, Roth J, Mehran R, Hofstetter W, Antonoff M, Fossella F, Mott F, Le X, ... ... Kurie J, et al. OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study Journal of Thoracic Oncology. 14: S241-S242. DOI: 10.1016/J.Jtho.2019.08.481 |
0.45 |
|
| 2018 |
Kawakami M, Mustachio LM, Zheng L, Chen Y, Rodriguez-Canales J, Mino B, Kurie JM, Roszik J, Villalobos PA, Thu KL, Silvester J, Cescon DW, Wistuba II, Mak TW, Liu X, et al. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers. Proceedings of the National Academy of Sciences of the United States of America. PMID 29434041 DOI: 10.1073/Pnas.1719760115 |
0.533 |
|
| 2018 |
Guo HF, Tsai CL, Terajima M, Tan X, Banerjee P, Miller MD, Liu X, Yu J, Byemerwa J, Alvarado S, Kaoud TS, Dalby KN, Bota-Rabassedas N, Chen Y, Yamauchi M, ... ... Kurie JM, et al. Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding. Nature Communications. 9: 512. PMID 29410444 DOI: 10.1038/S41467-018-02859-Z |
0.303 |
|
| 2018 |
Tan X, Banerjee P, Liu X, Yu J, Gibbons DL, Wu P, Scott KL, Diao L, Zheng X, Wang J, Jalali A, Suraokar M, Fujimoto J, Behrens C, Liu X, ... ... Kurie JM, et al. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. The Journal of Clinical Investigation. PMID 29324442 DOI: 10.1172/Jci97225 |
0.381 |
|
| 2018 |
Yamauchi M, Barker TH, Gibbons DL, Kurie JM. The fibrotic tumor stroma. The Journal of Clinical Investigation. 128: 16-25. PMID 29293090 DOI: 10.1172/Jci93554 |
0.34 |
|
| 2018 |
Kawakami M, Mustachio LM, Zheng L, Chen Y, Rodriguez-Canales J, Mino B, Kurie JM, Roszik J, Villalobos PA, Thu KL, Cescon DW, Silvester J, Wistuba I, Mak TW, Liu X, et al. Abstract 1948: Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers Cancer Research. 78: 1948-1948. DOI: 10.1158/1538-7445.Am2018-1948 |
0.528 |
|
| 2018 |
Heymach J, Negrao M, Robichaux J, Carter B, Patel A, Altan M, Gibbons D, Fossella F, Simon G, Lam V, Blumenschein G, Tsao A, Kurie J, Mott F, Jenkins D, et al. OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology. 13: S323-S324. DOI: 10.1016/J.Jtho.2018.08.243 |
0.465 |
|
| 2018 |
Lin S, Lin X, Clay D, Yao L, Mok I, Gomez D, Kurie J, Simon G, Blumenschein G, Young J, Phan S, Sandler A, Papadimitrakopoulou V, Heymach J, Tsao A. OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.237 |
0.421 |
|
| 2017 |
Schliekelman MJ, Creighton CJ, Baird BN, Chen Y, Banerjee P, Bota-Rabassedas N, Ahn YH, Roybal JD, Chen F, Zhang Y, Mishra DK, Kim MP, Liu X, Mino B, Villalobos P, ... ... Kurie JM, et al. Thy-1(+) Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. Scientific Reports. 7: 6478. PMID 28744021 DOI: 10.1038/S41598-017-06922-5 |
0.504 |
|
| 2017 |
Kim JS, Kim EJ, Kim HS, Kurie JM, Ahn YH. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing. Biochemical and Biophysical Research Communications. PMID 28733031 DOI: 10.1016/J.Bbrc.2017.07.099 |
0.364 |
|
| 2017 |
Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X, Herbst RS, Toyooka S, Girard L, Minna JD, Kurie JM, et al. JAK1/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer. Molecular Cancer Therapeutics. PMID 28729401 DOI: 10.1158/1535-7163.Mct-17-0148 |
0.417 |
|
| 2017 |
Chen Y, Terajima M, Banerjee P, Guo H, Liu X, Yu J, Yamauchi M, Kurie JM. FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch. Scientific Reports. 7: 46021. PMID 28378777 DOI: 10.1038/Srep46021 |
0.311 |
|
| 2017 |
Lin SH, Lin Y, Price J, Parker M, Gomez DR, Welsh JW, Komaki R, Kurie JM, Simon GR, Blumenschein GR, Young JA, Phan S, Sandler A, Papadimitrakopoulou V, Heymach J, et al. DETERRED: PD-L1 blockade to evaluate the safety of lung cancer therapy using carboplatin, paclitaxel, and radiation combined with MPDL3280A (atezolizumab). Journal of Clinical Oncology. 35: 3064-3064. DOI: 10.1200/Jco.2017.35.15_Suppl.3064 |
0.328 |
|
| 2017 |
Kawakami M, Roszik J, Zheng L, Kurie J, Mustachio LM, Liu X, Dmitrovsky E. Abstract 128: The next-generation CDK2/9 inhibitor CYC065 elicits marked antineoplastic effects in lung cancer by engaging antimetastatic pathways Cancer Research. 77: 128-128. DOI: 10.1158/1538-7445.Am2017-128 |
0.528 |
|
| 2017 |
Elamin Y, Robichaux J, Lam V, Tsao A, Lu C, Blumenschein G, Kurie J, Brahmer J, Li S, Chen T, Estrada-Bernal A, Truini A, Nilsson M, Le A, Tan Z, et al. OA 12.01 The Preclinical and Clinical Activity of Poziotinib, a Potent, Selective Inhibitor of EGFR Exon 20 Mutant NSCLC Journal of Thoracic Oncology. 12: S1776. DOI: 10.1016/J.Jtho.2017.09.394 |
0.344 |
|
| 2017 |
Banerjee P, Tan X, Kurie JM. A Confocal Super-Resolution Approach to Study the Dynamics of Golgi Apparatus in Lung Cancer Metastasis Biophysical Journal. 112: 238. DOI: 10.1016/J.Bpj.2016.11.1302 |
0.39 |
|
| 2016 |
Chen L, Yi X, Goswami S, Ahn YH, Roybal JD, Yang Y, Diao L, Peng D, Peng D, Fradette JJ, Wang J, Byers LA, Kurie JM, Ullrich SE, Qin FX, et al. Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression. Oncoimmunology. 5: e1234570. PMID 27999749 DOI: 10.1080/2162402X.2016.1234570 |
0.459 |
|
| 2016 |
Tan X, Banerjee P, Guo HF, Ireland S, Pankova D, Ahn YH, Nikolaidis IM, Liu X, Zhao Y, Xue Y, Burns AR, Roybal J, Gibbons DL, Zal T, Creighton CJ, ... ... Kurie JM, et al. Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11. The Journal of Clinical Investigation. PMID 27869652 DOI: 10.1172/Jci88736 |
0.372 |
|
| 2016 |
Chen Y, Guo H, Terajima M, Banerjee P, Liu X, Yu J, Momin A, Katayama H, Hanash S, Burns A, Fields G, Yamauchi M, Kurie J. Lysyl Hydroxylase 2 Is Secreted By Tumor Cells and Can Modify Collagen in the Extracellular Space. The Journal of Biological Chemistry. PMID 27803159 DOI: 10.1074/Jbc.M116.759803 |
0.46 |
|
| 2016 |
Chen F, Zhang Y, Parra E, Rodriguez J, Behrens C, Akbani R, Lu Y, Kurie JM, Gibbons DL, Mills GB, Wistuba II, Creighton CJ. Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. PMID 27775076 DOI: 10.1038/Onc.2016.303 |
0.424 |
|
| 2016 |
Kudinov AE, Deneka A, Nikonova AS, Beck TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, Cai KQ, Yaghmour KM, Baker KA, Egleston BL, Nicolas E, ... ... Kurie JM, et al. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27274057 DOI: 10.1073/Pnas.1513616113 |
0.508 |
|
| 2016 |
Kim JS, Kurie JM, Ahn Y. Abstract 1908: Lung tumorigenesis and metastasis is suppressed by the miR-200-GATA4/6-BMP4 axis Cancer Research. 76: 1908-1908. DOI: 10.1158/1538-7445.Am2016-1908 |
0.432 |
|
| 2016 |
Kudinov A, Deneka A, Nikonova A, Serebriiskii I, Beck TN, Cai Q, Egleston BL, Nicolas E, Borghaei H, Gibbons D, Kurie J, Golemis EA, Boumber Y. Abstract 1584: Musashi-2 (MSI2) drives TGFBR1/SMAD3 dependent partial EMT and supports VEGFR2 expression and metastasis of human and mouse NSCLC cells Cancer Research. 76: 1584-1584. DOI: 10.1158/1538-7445.Am2016-1584 |
0.507 |
|
| 2015 |
Pankoval D, Chen Y, Terajima M, Schliekelman MJ, Baird BN, Fahrenholtz M, Sun L, Gill BJ, Vadakkan TJ, Kim MP, Ahn YH, Roybal JD, Liu X, Parra Cuentas ER, Rodriguez J, ... ... Kurie JM, et al. Cancer-associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma. Molecular Cancer Research : McR. PMID 26631572 DOI: 10.1158/1541-7786.Mcr-15-0307 |
0.435 |
|
| 2015 |
Kim JS, Kurie JM, Ahn YH. BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells. Molecular Cancer. 14: 173. PMID 26395571 DOI: 10.1186/S12943-015-0441-Y |
0.435 |
|
| 2015 |
Mishra DK, Compean SD, Thrall MJ, Liu X, Massarelli E, Kurie JM, Kim MP. Human Lung Fibroblasts Inhibit Non-Small Cell Lung Cancer Metastasis in Ex Vivo 4D Model. The Annals of Thoracic Surgery. PMID 26233278 DOI: 10.1016/J.Athoracsur.2015.05.014 |
0.461 |
|
| 2015 |
Lee JW, Park HS, Park SA, Ryu SH, Meng W, Jürgensmeier JM, Kurie JM, Hong WK, Boyer JL, Herbst RS, Koo JS. A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress. Plos One. 10: e0122628. PMID 25897662 DOI: 10.1371/Journal.Pone.0122628 |
0.518 |
|
| 2015 |
Chen Y, Terajima M, Yang Y, Sun L, Ahn YH, Pankova D, Puperi DS, Watanabe T, Kim MP, Blackmon SH, Rodriguez J, Liu H, Behrens C, Wistuba II, Minelli R, ... ... Kurie JM, et al. Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. The Journal of Clinical Investigation. 125: 1147-62. PMID 25664850 DOI: 10.1172/Jci74725 |
0.389 |
|
| 2015 |
Chen L, Goswami S, Yi X, Byers L, Diao L, Roybal J, Ungewiss C, Peng D, Wang J, Wistuba I, Chen L, Ullrich S, Heymach J, Kurie J, Qin X, et al. Abstract B67: A big role in tumor immune microenvironment of a small non-coding RNA: microRNA-200 Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-B67 |
0.434 |
|
| 2015 |
Mishra DK, Thrall MJ, Kurie JM, Kim MP. Abstract B31: Lung fibroblast enhances MMP-1 secretion when co-cultured with human lung cancer cells in the 4D lung cancer model Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B31 |
0.476 |
|
| 2015 |
Kudinov A, Deneka AD, Nikonova A, Ahn Y, Liu XL, Serebriiskii I, Efimov A, Yang D, Andrake MA, Nicolas E, Egleston B, Borghaei H, Gibbons D, Kurie J, Golemis E, et al. Abstract 4098: Musashi-2 (MSI2) activates TGF-β signaling and inhibits CLDN7 to promote non-small cell lung cancer (NSCLC) metastasis Cancer Research. 75: 4098-4098. DOI: 10.1158/1538-7445.Am2015-4098 |
0.522 |
|
| 2014 |
Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, Zhang X, Yi X, Dwyer D, Lin W, Diao L, Wang J, Roybal JD, Patel M, Ungewiss C, ... ... Kurie JM, et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nature Communications. 5: 5241. PMID 25348003 DOI: 10.1038/Ncomms6241 |
0.37 |
|
| 2014 |
Vishnoi M, Mishra DK, Thrall MJ, Kurie JM, Kim MP. Circulating tumor cells from a 4-dimensional lung cancer model are resistant to cisplatin. The Journal of Thoracic and Cardiovascular Surgery. 148: 1056-63; discussion . PMID 25129597 DOI: 10.1016/J.Jtcvs.2014.05.059 |
0.451 |
|
| 2014 |
Yang Y, Ahn YH, Chen Y, Tan X, Guo L, Gibbons DL, Ungewiss C, Peng DH, Liu X, Lin SH, Thilaganathan N, Wistuba II, Rodriguez-Canales J, McLendon G, Creighton CJ, ... Kurie JM, et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. The Journal of Clinical Investigation. 124: 2696-708. PMID 24762440 DOI: 10.1172/Jci72171 |
0.496 |
|
| 2014 |
Gibbons DL, Byers LA, Kurie JM. Smoking, p53 mutation, and lung cancer. Molecular Cancer Research : McR. 12: 3-13. PMID 24442106 DOI: 10.1158/1541-7786.Mcr-13-0539 |
0.391 |
|
| 2014 |
Mishra DK, Creighton CJ, Zhang Y, Gibbons DL, Kurie JM, Kim MP. Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients. International Journal of Cancer. Journal International Du Cancer. 134: 789-98. PMID 23934967 DOI: 10.1002/Ijc.28428 |
0.433 |
|
| 2014 |
Gibbons DL, Chen L, Goswami S, Cortez MA, Ahn Y, Byers LA, Lin W, Diao L, Wang J, Roybal J, Ungewiss C, Antonia SJ, Mediaville-Varela M, Suraokar MB, Welsh J, ... ... Kurie JM, et al. Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis. Journal of Clinical Oncology. 32: 8063-8063. DOI: 10.1200/Jco.2014.32.15_Suppl.8063 |
0.438 |
|
| 2014 |
Lou Y, Diao L, Byers LA, Gibbons DL, Denning W, Wang J, Papadimitrakopoulou V, Wistuba II, Goswami S, Cortez MA, Welsh J, Kurie JM, Heymach J. Association of epithelial-mesenchymal transition status with PD1/PDL1 expression and a distinct immunophenotype in non-small cell lung cancer: Implications for immunotherapy biomarkers. Journal of Clinical Oncology. 32: 3018-3018. DOI: 10.1200/Jco.2014.32.15_Suppl.3018 |
0.437 |
|
| 2014 |
Gibbons DL, Chen L, Goswami S, Ahn Y, Byers LA, Diao L, Wang J, Cortez A, Roybal J, Welsh J, Zhang X, Dwyer D, Yi X, Lieping C, Wistuba I, ... ... Kurie JM, et al. Abstract A21: microRNA-200 regulates tumor cell PD-L1 expression to control lung cancer metastasis. Clinical Cancer Research. 20: A21-A21. DOI: 10.1158/1078-0432.14Aacriaslc-A21 |
0.424 |
|
| 2014 |
Kim M, Mishra D, Thrall M, Creighton C, Gibbons D, Kurie J, Kim M. A549 and H1299 Cells Form Metastatic Lesions in the Ex Vivo 4D Lung Cancer Model Journal of Surgical Research. 186: 557-558. DOI: 10.1016/J.Jss.2013.11.469 |
0.398 |
|
| 2013 |
Creighton CJ, Gibbons DL, Kurie JM. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Management and Research. 5: 187-95. PMID 23986650 DOI: 10.2147/Cmar.S35171 |
0.431 |
|
| 2013 |
Baird BN, Schliekelman MJ, Ahn YH, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y, Patel M, Liu X, Thilaganathan N, Larina IV, Dickinson ME, ... ... Kurie JM, et al. Fibulin-2 is a driver of malignant progression in lung adenocarcinoma. Plos One. 8: e67054. PMID 23785517 DOI: 10.1371/Journal.Pone.0067054 |
0.424 |
|
| 2013 |
Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L, Beumer JH, Anyang BN, Nugent W, Johnstone D, Tsongalis GJ, Kurie JM, Li H, Direnzo J, Guo Y, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Molecular Cancer Therapeutics. 12: 1545-55. PMID 23686769 DOI: 10.1158/1535-7163.Mct-12-0933 |
0.489 |
|
| 2013 |
Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, ... ... Kurie JM, et al. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Research. 73: 571-82. PMID 23204236 DOI: 10.1158/0008-5472.Can-12-0263 |
0.518 |
|
| 2013 |
Park HS, Lee JW, Saintigny P, Kurie JM, Herbst RS, Koo JP. Abstract 2878: Targeting the CXCL5-CXCR2-CREB signaling axis suppresses growth, survival, and invasion of lung adenocarcinoma. Cancer Research. 73: 2878-2878. DOI: 10.1158/1538-7445.Am2013-2878 |
0.501 |
|
| 2013 |
Boumber Y, Kudinov A, Liu X, Ahn Y, Rodriguez J, Wistuba I, Gibbons D, Kurie J. Abstract 2690: The role of musashi-1 in tumor progression in non-small cell lung cancer. Cancer Research. 73: 2690-2690. DOI: 10.1158/1538-7445.Am2013-2690 |
0.524 |
|
| 2013 |
Mishra DK, Creighton C, Zhang Y, Gibbons DL, Kurie JM, Kim MP. Abstract 1508: Gene expression analysis of perfusable nodules grown onex vivo3D model shows effects on extracellular matrix, cell signaling and immune response. Cancer Research. 73: 1508-1508. DOI: 10.1158/1538-7445.Am2013-1508 |
0.421 |
|
| 2012 |
Mishra DK, Sakamoto JH, Thrall MJ, Baird BN, Blackmon SH, Ferrari M, Kurie JM, Kim MP. Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture. Plos One. 7: e45308. PMID 23028922 DOI: 10.1371/Journal.Pone.0045308 |
0.405 |
|
| 2012 |
Schumacher MA, Min J, Link TM, Guan Z, Xu W, Ahn YH, Soderblom EJ, Kurie JM, Evdokimov A, Moseley MA, Lewis K, Brennan RG. Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Reports. 2: 518-25. PMID 22999936 DOI: 10.1016/J.Celrep.2012.08.013 |
0.345 |
|
| 2012 |
Gill BJ, Gibbons DL, Roudsari LC, Saik JE, Rizvi ZH, Roybal JD, Kurie JM, West JL. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Research. 72: 6013-23. PMID 22952217 DOI: 10.1158/0008-5472.Can-12-0895 |
0.375 |
|
| 2012 |
Ahn YH, Gibbons DL, Chakravarti D, Creighton CJ, Rizvi ZH, Adams HP, Pertsemlidis A, Gregory PA, Wright JA, Goodall GJ, Flores ER, Kurie JM. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. The Journal of Clinical Investigation. 122: 3170-83. PMID 22850877 DOI: 10.1172/Jci63608 |
0.388 |
|
| 2012 |
Chatterjee S, Seifried L, Feigin ME, Gibbons DL, Scuoppo C, Lin W, Rizvi ZH, Lind E, Dissanayake D, Kurie J, Ohashi P, Muthuswamy SK. Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells. Plos One. 7: e34343. PMID 22529912 DOI: 10.1371/Journal.Pone.0034343 |
0.352 |
|
| 2012 |
Mishra DK, Thrall MJ, Baird BN, Ott HC, Blackmon SH, Kurie JM, Kim MP. Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules. The Annals of Thoracic Surgery. 93: 1075-81. PMID 22385822 DOI: 10.1016/J.Athoracsur.2012.01.011 |
0.461 |
|
| 2012 |
Jeong Y, Kim J, Sato M, Lee W, Kurie JM, Minna JD, Mangelsdorf DJ. Abstract LB-521: Expression profile of nuclear receptor superfamily in a lung cancer pathogenesis model Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-521 |
0.479 |
|
| 2012 |
Mishra DK, Shen H, Mai J, Ott HC, Baird BN, Kurie JM, Kim MP. Abstract LB-112:Ex vivolung cancer nodule model shows efficacy of nanoparticle delivery Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-112 |
0.412 |
|
| 2012 |
Mishra DK, Baird BN, Ott HC, Gibbons DL, Kurie JM, Kim MP. Abstract 345: Circulating tumor cells from perfusable tumor nodules grown on decellularized rat lung scaffold has mesenchymal characteristics Cancer Research. 72: 345-345. DOI: 10.1158/1538-7445.Am2012-345 |
0.442 |
|
| 2011 |
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Research. 71: 7670-82. PMID 21987723 DOI: 10.1158/0008-5472.Can-11-0964 |
0.41 |
|
| 2011 |
Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, Kurie JM. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression. Molecular and Cellular Biology. 31: 4270-85. PMID 21896780 DOI: 10.1128/Mcb.05562-11 |
0.532 |
|
| 2011 |
Borok Z, Whitsett JA, Bitterman PB, Thannickal VJ, Kotton DN, Reynolds SD, Krasnow MA, Bianchi DW, Morrisey EE, Hogan BL, Kurie JM, Walker DC, Radisky DC, Nishimura SL, Violette SM, et al. Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010. Proceedings of the American Thoracic Society. 8: 215-22. PMID 21653526 DOI: 10.1513/pats.201012-067CB |
0.304 |
|
| 2011 |
Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, et al. Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prevention Research (Philadelphia, Pa.). 4: 818-28. PMID 21636548 DOI: 10.1158/1940-6207.Capr-10-0376 |
0.483 |
|
| 2011 |
Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA, Goodall GJ, Kurie JM. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. The Journal of Clinical Investigation. 121: 1373-85. PMID 21403400 DOI: 10.1172/Jci42579 |
0.409 |
|
| 2011 |
Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, Baird BN, Alvarez C, Thilaganathan N, Liu DD, Saintigny P, Heymach JV, Creighton CJ, Kurie JM. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Molecular Cancer Research : McR. 9: 25-35. PMID 21115742 DOI: 10.1158/1541-7786.Mcr-10-0497 |
0.454 |
|
| 2011 |
Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer MA, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, et al. Abstract LB-412: Combining bexarotene with erlotinib in window of opportunity and phase II trials causes lung cancer responses independent of KRAS mutations Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-412 |
0.484 |
|
| 2011 |
Saintigny P, Liu D, Lee JJ, Ping Y, Behrens C, Soto LMS, Heymach JV, Kim ES, Hong WK, Kurie JM, Wistuba II, Koo JS. Abstract 392: CXCR2 expression in tumor cells is associated with an adverse outcome in a large set of non-small-cell lung cancer (NSCLC) Cancer Research. 71: 392-392. DOI: 10.1158/1538-7445.Am2011-392 |
0.459 |
|
| 2010 |
Xu L, Nilsson MB, Saintigny P, Cascone T, Herynk MH, Du Z, Nikolinakos PG, Yang Y, Prudkin L, Liu D, Lee JJ, Johnson FM, Wong KK, Girard L, Gazdar AF, ... ... Kurie JM, et al. Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells. Oncogene. 29: 2616-27. PMID 20154724 DOI: 10.1038/Onc.2010.16 |
0.472 |
|
| 2009 |
Gibbons DL, Lin W, Creighton C, Zhang S, Lozano G, Kurie J. Use of a murine model of NSCLC to evaluate the role of the microRNA-200 family in regulating EMT and metastasis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11006. PMID 27964037 DOI: 10.1200/Jco.2009.27.15_Suppl.11006 |
0.478 |
|
| 2009 |
Johnson FM, Tang X, Tran H, Saigal B, Erasmus J, Kurie J, Hwang L, Oh Y, Lippman S, Stewart DJ. Phase II study of dasatinib in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e19015. PMID 27962619 DOI: 10.1200/Jco.2009.27.15_Suppl.E19015 |
0.488 |
|
| 2009 |
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes & Development. 23: 2140-51. PMID 19759262 DOI: 10.1101/Gad.1820209 |
0.402 |
|
| 2009 |
Jin N, Cho SN, Raso MG, Wistuba I, Smith Y, Yang Y, Kurie JM, Yen R, Evans CM, Ludwig T, Jeong JW, DeMayo FJ. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis. Development (Cambridge, England). 136: 3347-56. PMID 19710174 DOI: 10.1242/Dev.032979 |
0.472 |
|
| 2009 |
Lee D, Yu M, Lee E, Kim H, Yang Y, Kim K, Pannicia C, Kurie JM, Threadgill DW. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. The Journal of Clinical Investigation. 119: 2702-13. PMID 19690388 DOI: 10.1172/Jci36435 |
0.435 |
|
| 2009 |
Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Wistuba II, Lozano G, Kurie JM. Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. Plos One. 4: e5401. PMID 19404390 DOI: 10.1371/Journal.Pone.0005401 |
0.499 |
|
| 2009 |
Choi K, Ahn YH, Gibbons DL, Tran HT, Creighton CJ, Girard L, Minna JD, Qin FX, Kurie JM. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. The Journal of Biological Chemistry. 284: 17766-74. PMID 19398556 DOI: 10.1074/Jbc.M109.003111 |
0.448 |
|
| 2009 |
Moghaddam SJ, Li H, Cho SN, Dishop MK, Wistuba II, Ji L, Kurie JM, Dickey BF, Demayo FJ. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. American Journal of Respiratory Cell and Molecular Biology. 40: 443-53. PMID 18927348 DOI: 10.1165/Rcmb.2008-0198Oc |
0.425 |
|
| 2009 |
Yang Y, Ahn Y, Gibbons DL, Zang Y, Lin W, Thilaganthan N, Moreira DC, Creighton CJ, Goodall GJ, Kurie JM. Abstract A29: The Notch ligand Jagged2 promotes metastasis through a GATA3/miR‐200 regulatory loop Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A29 |
0.406 |
|
| 2008 |
Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD, Jimenez CA, Eapen GA, Wistuba II, Kurie JM. A randomized double-blind study of the biological effects of celecoxib as a chemopreventive agent in current and former smokers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1501. PMID 27948315 DOI: 10.1200/Jco.2008.26.15_Suppl.1501 |
0.354 |
|
| 2008 |
Sun H, Chung WC, Ryu SH, Ju Z, Tran HT, Kim E, Kurie JM, Koo JS. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 1: 316-28. PMID 19138976 DOI: 10.1158/1940-6207.Capr-07-0002 |
0.401 |
|
| 2008 |
Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM. Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells. Cancer Prevention Research (Philadelphia, Pa.). 1: 201-7. PMID 19138957 DOI: 10.1158/1940-6207.CAPR-08-0014 |
0.41 |
|
| 2008 |
Zhong L, Roybal J, Chaerkady R, Zhang W, Choi K, Alvarez CA, Tran H, Creighton CJ, Yan S, Strieter RM, Pandey A, Kurie JM. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment Cancer Research. 68: 7237-7245. PMID 18757440 DOI: 10.1158/0008-5472.Can-08-1529 |
0.487 |
|
| 2008 |
Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED, Molldrem JJ, Wistuba II, Powis G, Demayo FJ, Kim CF, Kurie JM. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. Plos One. 3: e2220. PMID 18493606 DOI: 10.1371/Journal.Pone.0002220 |
0.482 |
|
| 2008 |
Yang Y, Wislez M, Fujimoto N, Prudkin L, Izzo JG, Uno F, Ji L, Hanna AE, Langley RR, Liu D, Johnson FM, Wistuba I, Kurie JM. A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Molecular Cancer Therapeutics. 7: 952-60. PMID 18413809 DOI: 10.1158/1535-7163.Mct-07-2045 |
0.494 |
|
| 2008 |
Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai WW, Sato M, Minna JD, Wu H, Creighton CJ, Demayo FJ, ... ... Kurie JM, et al. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Research. 68: 1119-27. PMID 18281487 DOI: 10.1158/0008-5472.Can-07-3117 |
0.411 |
|
| 2007 |
Choi K, Creighton CJ, Stivers D, Fujimoto N, Kurie JM. Transcriptional profiling of non-small cell lung cancer cells with activating EGFR somatic mutations Plos One. 2. PMID 18030354 DOI: 10.1371/Journal.Pone.0001226 |
0.482 |
|
| 2007 |
Gray J, Mao JT, Szabo E, Kelley M, Kurie J, Bepler G. Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest. 132: 56. PMID 17873160 DOI: 10.1378/Chest.07-1348 |
0.427 |
|
| 2007 |
Sethi G, Kwang SA, Xia D, Kurie JM, Aggarwal BB. Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-κB activation and NF-κB-regulated antiapoptotic gene products Journal of Immunology. 179: 1926-1933. PMID 17641059 DOI: 10.4049/Jimmunol.179.3.1926 |
0.725 |
|
| 2007 |
Settleman J, Kurie JM. Drugging the bad "AKT-TOR" to overcome TKI-resistant lung cancer. Cancer Cell. 12: 6-8. PMID 17613432 DOI: 10.1016/J.Ccr.2007.06.010 |
0.462 |
|
| 2007 |
Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G. A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene. 26: 6896-904. PMID 17486075 DOI: 10.1038/Sj.Onc.1210493 |
0.465 |
|
| 2007 |
Haigis KM, Wistuba II, Kurie JM. Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question. Genes & Development. 21: 361-6. PMID 17322395 DOI: 10.1101/Gad.1532107 |
0.395 |
|
| 2007 |
Zhang J, Kalyankrishna S, Wislez M, Thilaganathan N, Saigal B, Wei W, Ma L, Wistuba II, Johnson FM, Kurie JM. SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. The American Journal of Pathology. 170: 366-76. PMID 17200208 DOI: 10.2353/Ajpath.2007.060706 |
0.501 |
|
| 2007 |
Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. The Journal of Biological Chemistry. 282: 3507-19. PMID 17158870 DOI: 10.1074/Jbc.M610141200 |
0.767 |
|
| 2007 |
Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, Ma L, Hanna AE, Liu D, Girard L, Kim YH, Pollack JR, Minna JD, Wistuba II, Kurie JM. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene. 26: 2658-66. PMID 17057737 DOI: 10.1038/Sj.Onc.1210050 |
0.496 |
|
| 2006 |
Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, Mao L, Wistuba I, Strieter RM, Kurie JM. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Research. 66: 4198-207. PMID 16618742 DOI: 10.1158/0008-5472.Can-05-3842 |
0.409 |
|
| 2006 |
Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JM. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. The Biochemical Journal. 395: 653-62. PMID 16417524 DOI: 10.1042/Bj20051794 |
0.764 |
|
| 2005 |
Ji L, Kawashima H, Lu C, Kurie J, Chada S, Minna JD, Roth JA. Synergistic inhibition of EGFR tyrosine kinase and tumor cell growth in non-small cell lung cancer (NSCLC) by combination treatment with FUS1-nanoparticles and gefitinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7081. PMID 27944549 DOI: 10.1200/Jco.2005.23.16_Suppl.7081 |
0.487 |
|
| 2005 |
Fujimoto N, Wislez M, Zhang J, Iwanaga K, Dackor J, Hanna AE, Kalyankrishna S, Cody DD, Price RE, Sato M, Shay JW, Minna JD, Peyton M, Tang X, Massarelli E, ... ... Kurie JM, et al. High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. Cancer Research. 65: 11478-85. PMID 16357156 DOI: 10.1158/0008-5472.Can-05-1977 |
0.471 |
|
| 2005 |
Mann KK, Padovani AM, Guo Q, Colosimo AL, Lee HY, Kurie JM, Miller WH. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation. The Journal of Clinical Investigation. 115: 2924-33. PMID 16184197 DOI: 10.1172/Jci23628 |
0.34 |
|
| 2005 |
Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD, Price RE, Hittelman WN, Wistuba II, Kurie JM. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Research. 65: 3226-35. PMID 15833854 DOI: 10.1158/0008-5472.Can-04-4420 |
0.353 |
|
| 2005 |
Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, ... Kurie JM, et al. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Research. 65: 226-35. PMID 15665299 |
0.348 |
|
| 2005 |
Srinivas H, Juroske DM, Kalyankrishna S, Cody DD, Price RE, Xu XC, Narayanan R, Weigel NL, Kurie JM. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Molecular and Cellular Biology. 25: 1054-69. PMID 15657432 DOI: 10.1128/Mcb.25.3.1054-1069.2005 |
0.43 |
|
| 2004 |
Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, Milchgrub S, Smith AL, Souza RF, Gilbey L, Zhang X, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Research. 64: 9027-34. PMID 15604268 DOI: 10.1158/0008-5472.Can-04-3703 |
0.482 |
|
| 2004 |
Kurie JM. Role of protein kinase B-dependent signaling in lung tumorigenesis. Chest. 125: 141S-4S. PMID 15136468 DOI: 10.1378/Chest.125.5_Suppl.141S-A |
0.487 |
|
| 2004 |
Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, ... ... Kurie J, et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. International Journal of Radiation Oncology, Biology, Physics. 58: 1369-77. PMID 15050312 DOI: 10.1016/J.Ijrobp.2003.10.005 |
0.384 |
|
| 2004 |
Lee HY, Suh YA, Kosmeder JW, Pezzuto JM, Hong WK, Kurie JM. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1074-9. PMID 14871987 DOI: 10.1158/1078-0432.Ccr-0833-3 |
0.493 |
|
| 2003 |
Minna JD, Kurie JM, Jacks T. A big step in the study of small cell lung cancer. Cancer Cell. 4: 163-6. PMID 14522249 DOI: 10.1016/S1535-6108(03)00221-6 |
0.465 |
|
| 2003 |
Johnson FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer. Oncology (Williston Park, N.Y.). 17: 17-21. PMID 12886869 |
0.396 |
|
| 2003 |
Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 660-4. PMID 12869408 |
0.381 |
|
| 2003 |
Lu C, Komaki R, Lee JS, Shin DM, Palmer JL, Coldman BJ, Pisters KM, Kurie JM, Fossella FV, Glisson BS. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 2085-91. PMID 12796372 |
0.341 |
|
| 2003 |
Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival. The Journal of Biological Chemistry. 278: 23630-8. PMID 12714585 DOI: 10.1074/Jbc.M300997200 |
0.772 |
|
| 2003 |
Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, ... ... Kurie JM, et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 93-101. PMID 12538456 |
0.317 |
|
| 2002 |
Lee HY, Suh YA, Lee JI, Hassan KA, Mao L, Force T, Gilbert BE, Jacks T, Kurie JM. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2970-5. PMID 12231543 |
0.311 |
|
| 2002 |
Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, et al. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. Cancer. 95: 340-53. PMID 12124835 DOI: 10.1002/Cncr.10629 |
0.322 |
|
| 2002 |
Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Research. 62: 3530-7. PMID 12068000 |
0.409 |
|
| 2002 |
Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1178-84. PMID 12006535 |
0.375 |
|
| 2002 |
Komaki R, Lee JS, Kaplan B, Allen P, Kelly JF, Liao Z, Stevens CW, Fossella FV, Zinner R, Papadimitrakopoulou V, Khuri F, Glisson B, Pisters K, Kurie J, Herbst R, et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Seminars in Radiation Oncology. 12: 46-9. PMID 11917284 DOI: 10.1053/Srao.2002.31363 |
0.349 |
|
| 2001 |
Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh G, Ro JY, Broxson A, Hong WK, Hittelman WN. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. Journal of the National Cancer Institute. 93: 1081-8. PMID 11459869 DOI: 10.1093/Jnci/93.14.1081 |
0.361 |
|
| 2000 |
Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobb MH, Mangelsdorf DJ, Kurie JM. Stress pathway activation induces phosphorylation of retinoid X receptor. The Journal of Biological Chemistry. 275: 32193-9. PMID 10938283 DOI: 10.1074/Jbc.M005490200 |
0.363 |
|
| 2000 |
Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and Apoptosis Journal of Biological Chemistry. 275: 33607-33613. PMID 10874028 DOI: 10.1074/Jbc.M002547200 |
0.305 |
|
| 2000 |
Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano RJ, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, et al. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Therapy. 7: 530-6. PMID 10811470 DOI: 10.1038/Sj.Cgt.7700138 |
0.352 |
|
| 2000 |
Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Weill D, Wait J, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 609-22. PMID 10653876 DOI: 10.1200/Jco.2000.18.3.609 |
0.392 |
|
| 2000 |
Fossella FV, Zinner RG, Komaki R, Jung M, Jhingran A, Glisson BS, Pisters KM, Stevens CW, Khuri FR, Kurie JM, Lee JS, Herbst RS, Liao Z, Hong WK. Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC) Lung Cancer. 29: 111-112. DOI: 10.1016/S0169-5002(00)80369-4 |
0.421 |
|
| 2000 |
Herbst R, Khuri F, Jung M, Fossella F, Lee J, Glisson B, Shin D, Pisters K, Papadimitrakopoulou V, Kurie J, Perez-Soler R, Liu D, Lu C, Guerra M, Munden R, et al. Phase II study of combination weekly gemcitabine and vinorelbine in patients with untreated or previously treated non-small cell lung cancer Lung Cancer. 29: 12. DOI: 10.1016/S0169-5002(00)80033-1 |
0.454 |
|
| 2000 |
Lee JS, Pisters KM, Komaki R, Terry K, Glisson BS, Perez-Soler R, Fossella FV, Shin DM, Herbst RS, Khuri FR, Kurie JM, Hong WK. Systemic chemotherapy as a primary treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) Lung Cancer. 29: 4. DOI: 10.1016/S0169-5002(00)80004-5 |
0.438 |
|
| 1999 |
Glisson BS, Kurie JM, Perez-Soler R, Fox NJ, Murphy WK, Fossella FV, Lee JS, Ross MB, Nyberg DA, Pisters KM, Shin DM, Hong WK. Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 2309-15. PMID 10561292 DOI: 10.1200/Jco.1999.17.8.2309 |
0.427 |
|
| 1999 |
Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. Journal of the National Cancer Institute. 91: 763-71. PMID 10328106 DOI: 10.1093/Jnci/91.9.763 |
0.382 |
|
| 1999 |
Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret F, Kurie JM. All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Molecular and Cellular Biology. 19: 1973-1980. PMID 10022884 DOI: 10.1128/Mcb.19.3.1973 |
0.43 |
|
| 1998 |
Glisson B, Komaki R, Lee JS, Shin DM, Fossella F, Murphy WK, Kurie J, Perez-Soler R, Schea R, Vadhan-Raj S. Integration of filgrastim into chemoradiation for limited small cell lung cancer: A phase I study International Journal of Radiation Oncology Biology Physics. 40: 331-336. PMID 9457817 DOI: 10.1016/S0360-3016(97)00709-8 |
0.359 |
|
| 1997 |
Khuri FR, Kurie JM, Hong WK. Chemoprevention of respiratory tract cancer Hematology/Oncology Clinics of North America. 11: 387-408. PMID 9209902 DOI: 10.1016/S0889-8588(05)70440-8 |
0.413 |
|
| 1997 |
Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK, Lotan R. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. Journal of the National Cancer Institute. 89: 624-9. PMID 9150186 DOI: 10.1093/Jnci/89.9.624 |
0.494 |
|
| 1997 |
Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, et al. Gene therapy strategies for lung cancer Lung Cancer. 18: 141. DOI: 10.1016/S0169-5002(97)83954-2 |
0.411 |
|
| 1997 |
Lee JS, Kurie JM, Mao L, Morice RC, Ro JY, Lippman SM, Walter RL, Hittelman N, Hong WK. Intermediate end point markers in chemoprevention trials of lung cancer Lung Cancer. 18: 88-89. DOI: 10.1016/S0169-5002(97)83912-8 |
0.416 |
|
| 1997 |
Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, et al. Gene replacement for lung cancer Lung Cancer. 18: 76. DOI: 10.1016/S0169-5002(97)83905-0 |
0.434 |
|
| 1996 |
Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp BL, Lee JJ, Kane J, Robinson RA, Lippman SM, Kurie JM, Huber MH, Raber MN, Hong WK. Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 503-13. PMID 8636764 DOI: 10.1200/Jco.1996.14.2.503 |
0.494 |
|
| 1995 |
Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids and chemoprevention: Clinical and basic studies Journal of Cellular Biochemistry. 59: 1-10. PMID 8538183 DOI: 10.1002/Jcb.240590802 |
0.347 |
|
| 1994 |
Kurie JM, Lippman SM, Hong WK. Potential of retinoids in cancer prevention Cancer Treatment Reviews. 20: 1-10. PMID 8293427 DOI: 10.1016/0305-7372(94)90008-6 |
0.343 |
|
| 1994 |
Kurie JM, Allopenna J, Dmitrovsky E. Retinoic acid stimulates protein kinase A-associated G proteins during human teratocarcinoma differentiation. Biochimica Et Biophysica Acta. 1222: 88-94. PMID 8186270 DOI: 10.1016/0167-4889(94)90028-0 |
0.33 |
|
| 1994 |
Miller WH, Maerz WJ, Kurie J, Moy D, Baselga J, Lucas DA, Grippo JF, Masui H, Dmitrovsky E. All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas. Differentiation; Research in Biological Diversity. 55: 145-52. PMID 8143931 DOI: 10.1046/J.1432-0436.1994.5520145.X |
0.321 |
|
| 1993 |
Kurie JM, Younes A, Miller WH, Burchert M, Chiu CF, Kolesnick R, Dmitrovsky E. Retinoic acid stimulates the protein kinase C pathway before activation of its beta-nuclear receptor during human teratocarcinoma differentiation. Biochimica Et Biophysica Acta. 1179: 203-7. PMID 8218362 DOI: 10.1016/0167-4889(93)90142-C |
0.337 |
|
| 1993 |
Kurie JM, Buck J, Eppinger TM, Moy D, Dmitrovsky E. 9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells Differentiation. 54: 123-129. DOI: 10.1111/J.1432-0436.1993.Tb01595.X |
0.315 |
|
| 1993 |
Kurie JM, Brown P, Salk E, Scheinberg D, Birrer M, Deutsch P, Dmitrovsky E. Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation Differentiation. 54: 115-122. DOI: 10.1111/J.1432-0436.1993.Tb01594.X |
0.339 |
|
| 1992 |
Rusch VW, Reuter VE, Kris MG, Kurie J, Miller WH, Nanus DM, Albino AP, Dmitrovsky E. Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer. The Journal of Thoracic and Cardiovascular Surgery. 104: 1465-1469. DOI: 10.1016/S0022-5223(19)34644-6 |
0.337 |
|
| Show low-probability matches. |